×
For best experience we recommend to activate Javascript in your browser.
Recombinant Thrombomodulin antibody (AA 325-481)
The Mouse Monoclonal anti-Thrombomodulin antibody has been validated for WB, IHC, FACS and IP. It is suitable to detect Thrombomodulin in samples from Human.
Quick Overview for Recombinant Thrombomodulin antibody (AA 325-481) (ABIN7608656)
Target
See all Thrombomodulin (THBD) Antibodies
Thrombomodulin (THBD)
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for Thrombomodulin antibodies
Human
Host
All hosts for Thrombomodulin antibodies
Mouse
Clonality
All clonalities for Thrombomodulin antibodies
Monoclonal
Conjugate
All conjugates for Thrombomodulin antibodies
This Thrombomodulin antibody is un-conjugated
Application
All applications for Thrombomodulin antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunoprecipitation (IP)
Clone
H3
Product Details anti-Thrombomodulin Antibody
(hide)
Binding Specificity
All epitopes for Thrombomodulin antibodies
AA 325-481
Purpose
Thrombomodulin () Recombinant Antibody
Sequence
Asp325~Asp481
Characteristics
The Thrombomodulin () Recombinant Antibody (Species: Human) has been validated for the following applications: WB, IFC, IHC, IP.
Purification
Protein A + Protein G affinity chromatography
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for Thrombomodulin
(hide)
Target
Thrombomodulin (THBD)
Alternative Name
Thrombomodulin
Gene ID
7056
UniProt
P07204
Recently viewed
(hide)
Chat with us , powered by LiveChat